2017

Genentech’s Actemra FDA approved for giant cell arteritis

Friday, May 26, 2017

Genentech, a member of the Roche Group, announced that the FDA has approved Actemra (tocilizumab) subcutaneous injection for the treatment of giant cell arteritis (GCA), a chronic and severe autoimmune condition. Actemra is the first therapy approved by the FDA for the treatment of adult patients with GCA. This is the sixth FDA approval for Actemra since the medicine was launched in 2010.

[Read More]

Worldwide Clinical Trials appoints Nowatkoski VP of Clinical Operations, Site Management

Friday, May 26, 2017

Worldwide Clinical Trials has announced the appointment of Karen Nowatkoski as vice president of Clinical Operations, Site Management. The role will involve partnering closely with senior leadership across the company to support Worldwide’s business strategy and goals. Nowatkoski will oversee and provide global management for the team of Clinical Operations Directors and Managers, as well as Clinical Research Associates.

[Read More]

Bioverativ to acquire True North Therapeutics

Thursday, May 25, 2017

Bioverativ, a global biotechnology company focused on the discovery, development and commercialization of innovative therapies for hemophilia and other rare blood disorders, has entered into a definitive agreement to acquire South San Francisco-based True North Therapeutics, a privately-held, clinical-stage rare disease biotechnology company, for an upfront payment of $400 million plus assumed cash. True North investors are also eligible to receive additional payments of up to $425 million contingent on the achievement of future development, regulatory and sales milestones.

[Read More]

Icon, Regeneron win Best Partnership in Clinical Research award from PharmaTimes

Thursday, May 25, 2017

Icon, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, and Regeneron Pharmaceuticals, a science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions, have won the Partnership in Clinical Research award at the 2017 PharmaTimes International Clinical Researcher of the Year Awards, which took place in London on 18th May. The companies were represented by Agnieszka Szpineta of Icon and Jacquie Kuritzky of Regeneron.

[Read More]